Protecting pregnant women from malaria in areas of high HIV infection prevalence.
Meshnick
Steven R
SR
Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599-7435, USA. meshnick@unc.edu
Mwapasa
Victor
V
Rogerson
Stephen J
SJ
D017954:Africa South of the Sahara / Q000453:epidemiology; D000962:Antimalarials / Q000008:administration & dosage* / Q000009:adverse effects; D018890:Chemoprevention; D004196:Disease Outbreaks; D004338:Drug Combinations; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000469:parasitology*; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000517:prevention & control* / Q000821:virology*; D015995:Prevalence; D011739:Pyrimethamine / Q000008:administration & dosage / Q000009:adverse effects; D013413:Sulfadoxine / Q000008:administration & dosage / Q000009:adverse effects; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000009:adverse effects
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D013413:Sulfadoxine; D011739:Pyrimethamine